Re‐admission during · patients with schizophrenia
It is very uncertain whether early warning signs training and treatment as usual changes service use: Rate of re‐hospitalisation compared with treatment (very low certainty).
1 finding from 1 review
Service use: Time to re‐hospitalisation · patients with schizophrenia
It is very uncertain whether early warning signs training and treatment as usual changes service use: Time to re‐hospitalisation compared with treatment (very low certainty).
1 finding from 1 review
Satisfaction with care · patients with schizophrenia
1 finding from 1 review
Adverse events: Lost to · patients with schizophrenia
It is very uncertain whether early warning signs training and treatment as usual changes adverse events: Lost to compared with treatment (very low certainty).
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
1 finding from 1 review
Relapse · patients with schizophrenia
ANY INTERMITTENT DRUG TECHNIQUE probably leads to higher relapse: long term (+ 26 weeks) as defined in each study compared with MAINTENANCE THERAPY (moderate certainty).
2 findings from 1 review
Global state: average score: long term (+ 26 weeks) Global Assessment Scale (GAS). Scale from: 0 to 100. · patients with schizophrenia
1 finding from 1 review
Mental state · patients with schizophrenia
1 finding from 1 review
Adverse effects: tardive dyskinesia: long term (+ 26 weeks) as defined in each study · patients with schizophrenia
INTERMITTENT (EARLY‐BASED) showed no clear difference in adverse effects: tardive dyskinesia: long term (+26 weeks) as… compared with MAINTENANCE THERAPY (low certainty).
1 finding from 1 review
Cost‐effectiveness · patients with schizophrenia
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
INTERMITTENT (EARLY‐BASED) may leads to higher leaving the study early/loss to compared with MAINTENANCE THERAPY (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
1 finding from 1 review
Hospital admissions · patients with schizophrenia
1 finding from 1 review
Global state: average score: long term (+ 26 weeks) Global Assessment Scale (GAS). Scale from: 0 to 100. · patients with schizophrenia
1 finding from 1 review
Mental state · patients with schizophrenia
1 finding from 1 review
Adverse effects: tardive dyskinesia: long term (+ 26 weeks) as defined in each study · patients with schizophrenia
1 finding from 1 review
Hospital admissions · patients with schizophrenia
ANY INTERMITTENT DRUG TECHNIQUE probably leads to higher hospitalisation: long term (+ 26 weeks) as defined in each study compared with MAINTENANCE THERAPY (moderate certainty).
2 findings from 1 review
Cost‐effectiveness · patients with schizophrenia
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether INTERMITTENT (CRISIS INTERVENTION) changes leaving the study early/ loss to compared with MAINTENANCE THERAPY (very low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
INTERMITTENT (GRADUALLY INCREASED DRUG‐FREE PERIODS) may leads to higher relapse: long term (+ 26 weeks) as defined in each study compared with MAINTENANCE THERAPY (low certainty).
1 finding from 1 review